Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.

Mazrooei P, Kron KJ, Zhu Y, Zhou S, Grillo G, Mehdi T, Ahmed M, Severson TM, Guilhamon P, Armstrong NS, Huang V, Yamaguchi TN, Fraser M, van der Kwast T, Boutros PC, He HH, Bergman AM, Bristow RG, Zwart W, Lupien M.

Cancer Cell. 2019 Dec 9;36(6):674-689.e6. doi: 10.1016/j.ccell.2019.10.005. Epub 2019 Nov 14.

PMID:
31735626
2.

Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems.

Garabedian PM, Wright A, Newbury I, Volk LA, Salazar A, Amato MG, Nathan AW, Forsythe KJ, Galanter WL, Kron K, Myers S, Abraham J, McCord SK, Eguale T, Bates DW, Schiff GD.

JAMA Netw Open. 2019 Mar 1;2(3):e191514. doi: 10.1001/jamanetworkopen.2019.1514.

3.

The Proteogenomic Landscape of Curable Prostate Cancer.

Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, Fraser M, Kron K, Murison A, Lupien M, Sahinalp C, Collins CC, Tetu B, Masoomian M, Berman DM, van der Kwast T, Bristow RG, Kislinger T, Boutros PC.

Cancer Cell. 2019 Mar 18;35(3):414-427.e6. doi: 10.1016/j.ccell.2019.02.005.

PMID:
30889379
4.

Divergent Diels-Alder Reactions in the Biosynthesis and Synthesis of Endiandric-Type Tetracycles: A Computational Study.

Kron KJ, Kosich M, Cave RJ, Vosburg DA.

J Org Chem. 2018 Sep 21;83(18):10941-10947. doi: 10.1021/acs.joc.8b01594. Epub 2018 Aug 30.

PMID:
30113843
5.

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.

Sonzogni O, Haynes J, Seifried LA, Kamel YM, Huang K, BeGora MD, Yeung FA, Robert-Tissot C, Heng YJ, Yuan X, Wulf GM, Kron KJ, Wagenblast E, Lupien M, Kislinger T, Hannon GJ, Muthuswamy SK.

PLoS Biol. 2018 Jun 20;16(6):e2004049. doi: 10.1371/journal.pbio.2004049. eCollection 2018 Jun.

6.

Incorporating medication indications into the prescribing process.

Kron K, Myers S, Volk L, Nathan A, Neri P, Salazar A, Amato MG, Wright A, Karmiy S, McCord S, Seoane-Vazquez E, Eguale T, Rodriguez-Monguio R, Bates DW, Schiff G.

Am J Health Syst Pharm. 2018 Jun 1;75(11):774-783. doi: 10.2146/ajhp170346. Epub 2018 Apr 19. Review.

PMID:
29674327
7.

Development and evaluation of a novel user interface for reviewing clinical microbiology results.

Wright A, Neri PM, Aaron S, Hickman TT, Maloney FL, Solomon DA, McEvoy D, Ai A, Kron K, Zuccotti G.

J Am Med Inform Assoc. 2018 Aug 1;25(8):1064-1068. doi: 10.1093/jamia/ocy014.

PMID:
29562338
8.

Core Components for a Clinically Integrated mHealth App for Asthma Symptom Monitoring.

Rudin RS, Fanta CH, Predmore Z, Kron K, Edelen MO, Landman AB, Zimlichman E, Bates DW.

Appl Clin Inform. 2017 Oct;8(4):1031-1043. doi: 10.4338/ACI-2017-06-RA-0096. Epub 2017 Dec 14.

9.

TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.

Kron KJ, Murison A, Zhou S, Huang V, Yamaguchi TN, Shiah YJ, Fraser M, van der Kwast T, Boutros PC, Bristow RG, Lupien M.

Nat Genet. 2017 Sep;49(9):1336-1345. doi: 10.1038/ng.3930. Epub 2017 Aug 7.

PMID:
28783165
10.

Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.

Olkhov-Mitsel E, Siadat F, Kron K, Liu L, Savio AJ, Trachtenberg J, Fleshner N, van der Kwast T, Bapat B.

Oncol Lett. 2017 Jul;14(1):390-396. doi: 10.3892/ol.2017.6140. Epub 2017 May 9.

11.

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.

Olkhov-Mitsel E, Savio AJ, Kron KJ, Pethe VV, Hermanns T, Fleshner NE, van Rhijn BW, van der Kwast TH, Zlotta AR, Bapat B.

Transl Oncol. 2017 Apr;10(2):168-177. doi: 10.1016/j.tranon.2017.01.001. Epub 2017 Feb 3.

12.

Genomic hallmarks of localized, non-indolent prostate cancer.

Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X, Masella AP, Fox NS, Xie M, Prokopec SD, Berlin A, Lalonde E, Ahmed M, Trudel D, Luo X, Beck TA, Meng A, Zhang J, D'Costa A, Denroche RE, Kong H, Espiritu SM, Chua ML, Wong A, Chong T, Sam M, Johns J, Timms L, Buchner NB, Orain M, Picard V, Hovington H, Murison A, Kron K, Harding NJ, P'ng C, Houlahan KE, Chu KC, Lo B, Nguyen F, Li CH, Sun RX, de Borja R, Cooper CI, Hopkins JF, Govind SK, Fung C, Waggott D, Green J, Haider S, Chan-Seng-Yue MA, Jung E, Wang Z, Bergeron A, Dal Pra A, Lacombe L, Collins CC, Sahinalp C, Lupien M, Fleshner NE, He HH, Fradet Y, Tetu B, van der Kwast T, McPherson JD, Bristow RG, Boutros PC.

Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9.

PMID:
28068672
13.

Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.

Bailey SD, Desai K, Kron KJ, Mazrooei P, Sinnott-Armstrong NA, Treloar AE, Dowar M, Thu KL, Cescon DW, Silvester J, Yang SY, Wu X, Pezo RC, Haibe-Kains B, Mak TW, Bedard PL, Pugh TJ, Sallari RC, Lupien M.

Nat Genet. 2016 Oct;48(10):1260-6. doi: 10.1038/ng.3650. Epub 2016 Aug 29.

14.

Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.

Inoue S, Li WY, Tseng A, Beerman I, Elia AJ, Bendall SC, Lemonnier F, Kron KJ, Cescon DW, Hao Z, Lind EF, Takayama N, Planello AC, Shen SY, Shih AH, Larsen DM, Li Q, Snow BE, Wakeham A, Haight J, Gorrini C, Bassi C, Thu KL, Murakami K, Elford AR, Ueda T, Straley K, Yen KE, Melino G, Cimmino L, Aifantis I, Levine RL, De Carvalho DD, Lupien M, Rossi DJ, Nolan GP, Cairns RA, Mak TW.

Cancer Cell. 2016 Aug 8;30(2):337-348. doi: 10.1016/j.ccell.2016.05.018. Epub 2016 Jul 14.

15.

Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.

Kamdar SN, Ho LT, Kron KJ, Isserlin R, van der Kwast T, Zlotta AR, Fleshner NE, Bader G, Bapat B.

Clin Epigenetics. 2016 Mar 15;8:32. doi: 10.1186/s13148-016-0195-4. eCollection 2016.

16.

Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation.

Planello AC, Singhania R, Kron KJ, Bailey SD, Roulois D, Lupien M, Line SR, de Souza AP, De Carvalho DD.

Oncotarget. 2016 Mar 29;7(13):15772-86. doi: 10.18632/oncotarget.7513.

17.

Enhancer alterations in cancer: a source for a cell identity crisis.

Kron KJ, Bailey SD, Lupien M.

Genome Med. 2014 Sep 23;6(9):77. doi: 10.1186/s13073-014-0077-3. eCollection 2014.

18.

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.

White-Al Habeeb NM, Ho LT, Olkhov-Mitsel E, Kron K, Pethe V, Lehman M, Jovanovic L, Fleshner N, van der Kwast T, Nelson CC, Bapat B.

Oncotarget. 2014 Sep 15;5(17):7858-69.

19.

Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.

Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, van der Kwast TH.

Eur J Cancer. 2014 Jun;50(9):1610-6. doi: 10.1016/j.ejca.2014.03.009. Epub 2014 Apr 3.

PMID:
24703897
20.

Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation.

Antignano F, Burrows K, Hughes MR, Han JM, Kron KJ, Penrod NM, Oudhoff MJ, Wang SK, Min PH, Gold MJ, Chenery AL, Braam MJ, Fung TC, Rossi FM, McNagny KM, Arrowsmith CH, Lupien M, Levings MK, Zaph C.

J Clin Invest. 2014 May;124(5):1945-55. doi: 10.1172/JCI69592. Epub 2014 Mar 25.

21.

Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.

Olkhov-Mitsel E, Zdravic D, Kron K, van der Kwast T, Fleshner N, Bapat B.

Sci Rep. 2014 Mar 21;4:4432. doi: 10.1038/srep04432.

22.

Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.

Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi KA, Diamandis EP.

Prostate. 2014 Apr;74(4):372-80. doi: 10.1002/pros.22758. Epub 2013 Dec 6.

PMID:
24311408
23.

Age estimates for the buckwheat family Polygonaceae based on sequence data calibrated by fossils and with a focus on the amphi-Pacific Muehlenbeckia.

Schuster TM, Setaro SD, Kron KA.

PLoS One. 2013 Apr 5;8(4):e61261. doi: 10.1371/journal.pone.0061261. Print 2013.

24.

Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer.

Kron K, Trudel D, Pethe V, Briollais L, Fleshner N, van der Kwast T, Bapat B.

Clin Cancer Res. 2013 Jul 1;19(13):3450-61. doi: 10.1158/1078-0432.CCR-12-3139. Epub 2013 Apr 2.

25.

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.

Olkhov-Mitsel E, Van der Kwast T, Kron KJ, Ozcelik H, Briollais L, Massey C, Recker F, Kwiatkowski M, Fleshner NE, Diamandis EP, Zlotta AR, Bapat B.

Epigenetics. 2012 Sep;7(9):1037-45. Epub 2012 Aug 9.

26.

Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer.

Kron K, Liu L, Trudel D, Pethe V, Trachtenberg J, Fleshner N, Bapat B, van der Kwast T.

Clin Cancer Res. 2012 May 15;18(10):2896-904. doi: 10.1158/1078-0432.CCR-11-2901. Epub 2012 Mar 27.

27.

Placing the woody tropical genera of Polygonaceae: A hypothesis of character evolution and phylogeny.

Burke JM, Sanchez A, Kron K, Luckow M.

Am J Bot. 2010 Aug;97(8):1377-90. doi: 10.3732/ajb.1000022. Epub 2010 Jul 26.

28.
29.

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

Liu L, Kron KJ, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L, van der Kwast TH, Bapat B.

Int J Cancer. 2011 Nov 15;129(10):2454-62. doi: 10.1002/ijc.25908. Epub 2011 Apr 13.

30.

How to Deal with Batch Effect in Sequential Microarray Experiments?

Demetrashvili N, Kron K, Pethe V, Bapat B, Briollais L.

Mol Inform. 2010 May 17;29(5):387-93. doi: 10.1002/minf.200900019. Epub 2010 May 14. No abstract available.

PMID:
27463194
31.

DNA methylation of HOXD3 as a marker of prostate cancer progression.

Kron KJ, Liu L, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L, van der Kwast TH, Bapat B.

Lab Invest. 2010 Jul;90(7):1060-7. doi: 10.1038/labinvest.2010.57. Epub 2010 Mar 8.

32.

Molecular phylogenetic relationships and a revised classification of the subfamily Ericoideae (Ericaceae).

Gillespie E, Kron K.

Mol Phylogenet Evol. 2010 Jul;56(1):343-54. doi: 10.1016/j.ympev.2010.02.028. Epub 2010 Mar 1.

PMID:
20193767
33.

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, Bapat B.

PLoS One. 2009;4(3):e4830. doi: 10.1371/journal.pone.0004830. Epub 2009 Mar 13.

34.

15q13.3 microdeletions increase risk of idiopathic generalized epilepsy.

Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, Franke A, Muhle H, de Kovel C, Baker C, von Spiczak S, Kron KL, Steinich I, Kleefuss-Lie AA, Leu C, Gaus V, Schmitz B, Klein KM, Reif PS, Rosenow F, Weber Y, Lerche H, Zimprich F, Urak L, Fuchs K, Feucht M, Genton P, Thomas P, Visscher F, de Haan GJ, Møller RS, Hjalgrim H, Luciano D, Wittig M, Nothnagel M, Elger CE, Nürnberg P, Romano C, Malafosse A, Koeleman BP, Lindhout D, Stephani U, Schreiber S, Eichler EE, Sander T.

Nat Genet. 2009 Feb;41(2):160-2. doi: 10.1038/ng.292. Epub 2009 Jan 11.

35.

Founder effect with variable age at onset in Arab families with Lafora disease and EPM2A mutation.

Gomez-Abad C, Afawi Z, Korczyn AD, Misk A, Shalev SA, Spiegel R, Lerman-Sagie T, Lev D, Kron KL, Gómez-Garre P, Serratosa JM, Berkovic SF.

Epilepsia. 2007 May;48(5):1011-4.

36.

Exploration of the genetic architecture of idiopathic generalized epilepsies.

Hempelmann A, Taylor KP, Heils A, Lorenz S, Prud'homme JF, Nabbout R, Dulac O, Rudolf G, Zara F, Bianchi A, Robinson R, Gardiner RM, Covanis A, Lindhout D, Stephani U, Elger CE, Weber YG, Lerche H, Nürnberg P, Kron KL, Scheffer IE, Mulley JC, Berkovic SF, Sander T.

Epilepsia. 2006 Oct;47(10):1682-90.

37.

Distinguishing sleep disorders from seizures: diagnosing bumps in the night.

Derry CP, Davey M, Johns M, Kron K, Glencross D, Marini C, Scheffer IE, Berkovic SF.

Arch Neurol. 2006 May;63(5):705-9. Erratum in: Arch Neurol. 2006 Jul;63(7):1037.

PMID:
16682539
39.

Phylogenetic analyses of Andromedeae (Ericaceae subfam. Vaccinioideae).

Kron KA, Judd WS, Crayn DM.

Am J Bot. 1999 Sep;86(9):1290-300.

40.
41.

Microscopic artifact found during examination of the skin: plant hair of Viburnum dentatum.

Fleischer AB Jr, Stonecipher M, Kron KA, Jaffe MJ.

Cutis. 1994 Jul;54(1):37-9.

PMID:
7924448
42.

The assessment of the bile salt-nondependent fraction of canalicular bile water in the rat.

Balabaud C, Kron KA, Gumucio JJ.

J Lab Clin Med. 1977 Feb;89(2):393-9.

PMID:
833475
43.

Bentonite flocculation test in rheumatoid arthritis.

DELTORO RA, SMITH RT, KRON KM, HERMANN IF, CLAPPIER MH.

J Am Med Assoc. 1959 Jan 24;169(4):315-7. No abstract available.

PMID:
13610663
44.

Increasing the effectiveness of gold therapy in rheumatoid arthritis.

SMITH RT, PEAK WP, KRON KM, HERMANN IF, DELTORO RA, GOLDMAN M.

J Am Med Assoc. 1958 Jul 5;167(10):1197-204. No abstract available.

PMID:
13549244
45.

Technique for extra-articular injection.

LIPOW EG, KRON KM, SMITH RT.

AMA Arch Surg. 1958 Jan;76(1):171-8. No abstract available.

PMID:
13487070
46.

Meprobamate (Miltown) in rheumatic diseases.

HERMANN IF, KRON KM, PEAK WP, SMITH RT.

J Am Med Assoc. 1957 Feb 16;163(7):535-8. No abstract available.

PMID:
13398299
47.

Zoxazolamine (flexin) in rheumatic diseases; preliminary report.

SMITH RT, KRON KM, PEAK WP, HERMANN IF.

J Am Med Assoc. 1956 Mar 3;160(9):745-8. No abstract available.

PMID:
13286125

Supplemental Content

Support Center